Table 2.
BIs (n = 120) | OBM-subtypes | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total(n = 205) | p-value | Lung cancer(n = 90) | p-value | Breast cancer(n = 60) | p-value | Prostate cancer(n = 30) | p-value | Gastric cancer(n = 11) | p-value | Rectal cancer(n = 5) | p-value | ||
Z | 12.14 ± 0.48 | 11.18 ± 0.68 | <0.001 | 11.18 ± 0.58 | <0.001 | 11.43 ± 0.94 | <0.001 | 11.40 ± 0.41 | <0.001 | 10.57 ± 0.26 | <0.001 | 11.33 ± 0.27 | 0.03 |
Rho | 571.57 ± 124.56 | 359.81 ± 128.92 | <0.001 | 354.89 ± 118.01 | <0.001 | 401.69 ± 135.60 | <0.001 | 442.95 ± 108.89 | <0.001 | 244.98 ± 47.02 | <0.001 | 411.17 ± 57.40 | 0.04 |
DEI | 0.08 ± 0.01 | 0.06 ± 0.01 | <0.001 | 0.06 ± 0.01 | <0.001 | 0.07 ± 0.01 | <0.001 | 0.07 ± 0.01 | <0.001 | 0.05 ± 0.01 | <0.001 | 0.07 ± 0.01 | 0.01 |
rCT | 646.04 ± 85.36 | 606.78 ± 119.19 | 0.002 | 610.77 ± 125.95 | 0.001 | 663.78 ± 140.71 | 0.995 | 648.35 ± 110.06 | 0.984 | 573.45 ± 13.74 | 0.261 | 670.16 ± 100.97 | 0.998 |